<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35927711</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Co-infection and enterovirus B: post EV-A71 mass vaccination scenario in China.</ArticleTitle><Pagination><StartPage>671</StartPage><MedlinePgn>671</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">671</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-022-07661-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hand, foot, and mouth disease (HFMD) is a common child infectious disease caused by more than 20 enterovirus (EV) serotypes. In recent years, enterovirus A71 (EV-A71) has been replaced by Coxsackievirus A6 (CV-A6) to become the predominant serotype. Multiple EV serotypes co-circulate in HFMD epidemics, and this study aimed to investigate the etiological epidemic characteristics of an HFMD outbreak in Kunming, China in 2019.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The clinical samples of 459 EV-associated HFMD patients in 2019 were used to amplify the VP1 gene region by the three sets of primers and identify serotypes using the molecular biology method. Phylogenetic analyses were performed based on the VP1 gene.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three hundred and forty-eight cases out of 459 HFMD patients were confirmed as EV infection. Of these 191 (41.61%) were single EV infections and 34.20% had co-infections. The EVs were assigned to 18 EV serotypes, of which CV-A6 was predominant (11.33%), followed by CV-B1 (8.93%), CV-A4 (5.23%), CV-A9 (4.58%), CV-A 16 (3.49%) and CV-A10 and CVA5 both 1.96%. Co-infection of CV-A6 with other EVs was present in 15.25% of these cases, followed by co-infection with CV-A16 and other EVs. The VP1 sequences used in the phylogenetic analyses showed that the CV-A6, CV-B1 and CV-A4 sequences belonged to the sub-genogroup D3 and genogroups F and E, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Co-circulation and co-infection of multiple serotypes were the etiological characteristic of the HFMD epidemic in Kunming China in 2019 with CV-A-6, CV-B1 and CV-A4 as the predominant serotypes. This is the first report of CV-B1 as a predominant serotype in China and may provide valuable information for the diagnosis, prevention and control of HFMD.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College (CAMS &amp; PUMC), 935 Jiao Ling Road, Kunming, 650118, Yunnan Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Danhan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College (CAMS &amp; PUMC), 935 Jiao Ling Road, Kunming, 650118, Yunnan Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Shanri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College (CAMS &amp; PUMC), 935 Jiao Ling Road, Kunming, 650118, Yunnan Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Zengqing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Kunming Children's Hospital, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Kunming Maternal and Child Health Hospital, Kunming, 650031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College (CAMS &amp; PUMC), 935 Jiao Ling Road, Kunming, 650118, Yunnan Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Changzeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College (CAMS &amp; PUMC), 935 Jiao Ling Road, Kunming, 650118, Yunnan Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Guohong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>First People's Hospital of Yunnan Province, Kunming, 650032, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College (CAMS &amp; PUMC), 935 Jiao Ling Road, Kunming, 650118, Yunnan Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhaoqing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College (CAMS &amp; PUMC), 935 Jiao Ling Road, Kunming, 650118, Yunnan Province, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Shaohui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences, and Peking Union Medical College (CAMS &amp; PUMC), 935 Jiao Ling Road, Kunming, 650118, Yunnan Province, People's Republic of China. shaohuima70@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Kunming, 650118, People's Republic of China. shaohuima70@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20200AA100009</GrantID><Agency>The Research Projects of Yunnan Province, China</Agency><Country/></Grant><Grant><GrantID>2017FA006</GrantID><Agency>The Research Projects of Yunnan Province, China</Agency><Country/></Grant><Grant><GrantID>202105AE160020</GrantID><Agency>Innovation Team Project of Yunnan Science and Technology Department</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032541" MajorTopicYN="N">Mass Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Co-circulation</Keyword><Keyword MajorTopicYN="N">Co-infection</Keyword><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Hand, foot, and mouth disease</Keyword></KeywordList><CoiStatement>The authors declare they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35927711</ArticleId><ArticleId IdType="pmc">PMC9354358</ArticleId><ArticleId IdType="doi">10.1186/s12879-022-07661-3</ArticleId><ArticleId IdType="pii">10.1186/s12879-022-07661-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang Y, Cao Z, Zeng D, Wang X, Wang Q. Using deep learning to predict the hand-foot-and-mouth disease of enterovirus A71 subtype in Beijing from 2011 to 2018. Sci Rep. 2020;10(1):12201. doi: 10.1038/s41598-020-68840-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68840-3</ArticleId><ArticleId IdType="pmc">PMC7376109</ArticleId><ArticleId IdType="pubmed">32699245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Long L, Xu L, Xiao Z, Hu S, Luo R, Wang H, Lu X, Xu Z, Yao X, Zhou L, et al. Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease. Sci Rep. 2016;6:23444. doi: 10.1038/srep23444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23444</ArticleId><ArticleId IdType="pmc">PMC4802311</ArticleId><ArticleId IdType="pubmed">27001010</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Zhang Z, Rao Q, Wang X, Wang M, Du T, Tang J, Long S, Zhang J, Luo J, et al. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China. Emerg Microbes Infect. 2021;10(1):619&#x2013;628. doi: 10.1080/22221751.2021.1899772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1899772</ArticleId><ArticleId IdType="pmc">PMC8018479</ArticleId><ArticleId IdType="pubmed">33682641</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, Zhao Y, Luo Y, Du L, Gan Q, Zhang H, Li J, Yang Z, Ma S. Ongoing change of severe hand, foot, and mouth disease pathogens in Yunnan, China, 2012 to 2016. J Med Virol. 2019;91(5):881&#x2013;885. doi: 10.1002/jmv.25393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25393</ArticleId><ArticleId IdType="pubmed">30613995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Center for Disease Control and Prevention. Guide of prevention and control for hand, foot and mouth disease; 2009. http://www.chinacdc.cn/jkzt/crb/bl/szkb/jszl_2275/200906/t20090612_24707.html. Accessed 20 Mar&#xa0;2020.</Citation></Reference><Reference><Citation>Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol. 2006;44(8):2698&#x2013;2704. doi: 10.1128/JCM.00542-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitch EC, Harvala H, Robertson I, Ubillos I, Templeton K, Simmonds P. Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region. J Clin Virol. 2009;44(2):119&#x2013;124. doi: 10.1016/j.jcv.2008.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2008.11.015</ArticleId><ArticleId IdType="pubmed">19135410</ArticleId></ArticleIdList></Reference><Reference><Citation>Iturriza-Gomara M, Megson B, Gray J. Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. J Med Virol. 2006;78(2):243&#x2013;253. doi: 10.1002/jmv.20533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20533</ArticleId><ArticleId IdType="pubmed">16372287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai Y, Zhang W, Wu J, Zhang J, Shen M, Yao S, Deng C, Li X, Wu D, Tian P, et al. Molecular epidemiology and clinical features of enteroviruses-associated hand, foot, and mouth disease and herpangina outbreak in Zunyi, China, 2019. Front Med (Lausanne) 2021;8:656699. doi: 10.3389/fmed.2021.656699.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.656699</ArticleId><ArticleId IdType="pmc">PMC8109248</ArticleId><ArticleId IdType="pubmed">33981716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Jiang L, Zhang C, He W, Tan Y, Ning C. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine. Vaccine. 2021;39(25):3319&#x2013;3323. doi: 10.1016/j.vaccine.2021.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.05.009</ArticleId><ArticleId IdType="pubmed">33994239</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Zhang H, Liu H, Zhang J, He L, Sun H, Huang X, Yang Z, Ma S. Molecular characteristics of hand, foot, and mouth disease for hospitalized pediatric patients in Yunnan, China. Medicine (Baltimore) 2018;97(31):e11610. doi: 10.1097/MD.0000000000011610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011610</ArticleId><ArticleId IdType="pmc">PMC6081097</ArticleId><ArticleId IdType="pubmed">30075535</ArticleId></ArticleIdList></Reference><Reference><Citation>Thammasonthijarern N, Kosoltanapiwat N, Nuprasert W, Sittikul P, Sriburin P, Pan-Ngum W, Maneekan P, Hataiyusuk S, Hattasingh W, Thaipadungpanit J, et al. Molecular epidemiological study of hand, foot, and mouth disease in a kindergarten-based setting in Bangkok, Thailand. Pathogens. 2021;10(5):576. doi: 10.3390/pathogens10050576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10050576</ArticleId><ArticleId IdType="pmc">PMC8150733</ArticleId><ArticleId IdType="pubmed">34068676</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C, Li Y, Zhou Y, Liang L, Turtle L, Wang F, Wu P, Qiu Q, Yang J, Wang K, et al. Enterovirus genomic load and disease severity among children hospitalised with hand, foot and mouth disease. EBioMedicine. 2020;62:103078. doi: 10.1016/j.ebiom.2020.103078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103078</ArticleId><ArticleId IdType="pmc">PMC7653080</ArticleId><ArticleId IdType="pubmed">33161231</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Jiang H, Tian X, Xia X, Huang T. Epidemiological characteristics of hand, foot, and mouth disease in Yunnan Province, China, 2008&#x2013;2019. BMC Infect Dis. 2021;21(1):751. doi: 10.1186/s12879-021-06462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06462-4</ArticleId><ArticleId IdType="pmc">PMC8336324</ArticleId><ArticleId IdType="pubmed">34348655</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S, Liao Q, Van Boeckel TP, Xing W, Sun J, Hsiao VY, Metcalf CJ, Chang Z, Liu F, Zhang J, et al. Hand, foot, and mouth disease in China: modeling epidemic dynamics of enterovirus serotypes and implications for vaccination. PLoS Med. 2016;13(2):e1001958. doi: 10.1371/journal.pmed.1001958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001958</ArticleId><ArticleId IdType="pmc">PMC4755668</ArticleId><ArticleId IdType="pubmed">26882540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X, Wan Z, Li Y, Hu Y, Jin X, Zhang C. National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol Sin. 2020;35(1):21&#x2013;33. doi: 10.1007/s12250-019-00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00169-2</ArticleId><ArticleId IdType="pmc">PMC7035399</ArticleId><ArticleId IdType="pubmed">31664644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Du Z, Feng M, Che Y, Li Q. A severe case of co-infection with Enterovirus 71 and vaccine-derived Poliovirus type II. J Clin Virol. 2015;72:25&#x2013;29. doi: 10.1016/j.jcv.2015.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.08.017</ArticleId><ArticleId IdType="pubmed">26361010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Zhang Y, Du C, Yang T, Liu Q, Pan Y, Chen J, Shi H, Sun Q, Liu L, et al. Dynamic constitution of the pathogens inducing encephalitis in hand, foot and mouth disease in Kunming, 2009&#x2013;2011. Jpn J Infect Dis. 2015;68(6):504&#x2013;510. doi: 10.7883/yoken.JJID.2014.428.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2014.428</ArticleId><ArticleId IdType="pubmed">25866107</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Du J, Hu Y, Wang X, Xue Y, Dong J, Sun L, Li Z, Li Y, Sun S, et al. Enterovirus coinfection during an outbreak of hand, foot, and mouth disease in Shandong, China. Clin Infect Dis. 2011;53(4):400&#x2013;401. doi: 10.1093/cid/cir346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cir346</ArticleId><ArticleId IdType="pubmed">21785005</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Zhang Y, Hou PQ, Zhu SY, Wu XY, Zhao H, Yu M, Qin CF. Human enterovirus co-infection in severe HFMD patients in China. J Clin Virol. 2014;61(4):621&#x2013;622. doi: 10.1016/j.jcv.2014.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.09.005</ArticleId><ArticleId IdType="pubmed">25449173</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zhang H, Zhao Y, Guo C, Yang Z, Ma S. Molecular characterization of a new human coxsackievirus B2 associated with severe hand-foot-mouth disease in Yunnan Province of China in 2012. Arch Virol. 2017;162(1):307&#x2013;311. doi: 10.1007/s00705-016-3075-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-3075-5</ArticleId><ArticleId IdType="pubmed">27709402</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Zhang Y, Liu L, Lu J, Guo X, Li H, Zeng H, Fang L, Xu W, Ke C. Isolation and characterization of a highly mutated Chinese isolate of enterovirus B84 from a patient with acute flaccid paralysis. Sci Rep. 2016;6:31059. doi: 10.1038/srep31059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31059</ArticleId><ArticleId IdType="pmc">PMC4976325</ArticleId><ArticleId IdType="pubmed">27499334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Shi Y, Miao L, Zhang C, Liu Y. Molecular epidemiology and recombination of enterovirus A71 in mainland China from 1987 to 2017. Int Microbiol. 2021;24(3):291&#x2013;299. doi: 10.1007/s10123-021-00164-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10123-021-00164-2</ArticleId><ArticleId IdType="pmc">PMC7895512</ArticleId><ArticleId IdType="pubmed">33608776</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F, Zhu R, Jia L, Song Q, Deng J, Liu L, Zhao L, Qian Y. Sub-genotype change and recombination of coxsackievirus A6s may be the cause of it being the predominant pathogen for HFMD in children in Beijing, as revealed by analysis of complete genome sequences. Int J Infect Dis. 2020;99:156&#x2013;162. doi: 10.1016/j.ijid.2020.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.07.010</ArticleId><ArticleId IdType="pubmed">32663604</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DM, Zhang Y, Scheuermann RH. Epidemiology and sequence-based evolutionary analysis of circulating non-polio enteroviruses. Microorganisms. 2020;8(12):1856. doi: 10.3390/microorganisms8121856.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8121856</ArticleId><ArticleId IdType="pmc">PMC7759938</ArticleId><ArticleId IdType="pubmed">33255654</ArticleId></ArticleIdList></Reference><Reference><Citation>Muslin C, Mac Kain A, Bessaud M, Blondel B, Delpeyroux F. Recombination in enteroviruses, a multi-step modular evolutionary process. Viruses. 2019;11(9):859. doi: 10.3390/v11090859.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11090859</ArticleId><ArticleId IdType="pmc">PMC6784155</ArticleId><ArticleId IdType="pubmed">31540135</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Wang J, Zhang Y, Sun D, Lu H, Han Z, Song Y, Yan D, Zhu S, Pei Y, et al. Coxsackievirus B4: an underestimated pathogen associated with a hand, foot, and mouth disease outbreak. Arch Virol. 2021;166(8):2225&#x2013;2234. doi: 10.1007/s00705-021-05128-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-05128-5</ArticleId><ArticleId IdType="pubmed">34091782</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YF, Yang F, Du J, Zhang T, Xue Y, Jin Q. Coxsackievirus B5, associated with neurological hand, foot and mouth disease, China. J Infect. 2012;65(2):189&#x2013;191. doi: 10.1016/j.jinf.2012.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2012.03.021</ArticleId><ArticleId IdType="pubmed">22484273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang HJ, Yoon Y, Lee YP, Kim HJ, Lee DY, Lee JW, Hyeon JY, Yoo JS, Lee S, Kang C, et al. A different epidemiology of enterovirus A and enterovirus B co-circulating in Korea, 2012&#x2013;2019. J Pediatr Infect Dis Soc. 2021;10(4):398&#x2013;407. doi: 10.1093/jpids/piaa111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa111</ArticleId><ArticleId IdType="pubmed">33150450</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention Increased detections and severe neonatal disease associated with coxsackievirus B1 infection&#x2013;United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(20):553&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">18496504</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikswo ME, Khetsuriani N, Fowlkes AL, Zheng X, Penaranda S, Verma N, Shulman ST, Sircar K, Robinson CC, Schmidt T, et al. Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007&#x2013;2008. Clin Infect Dis. 2009;49(5):e44&#x2013;51. doi: 10.1086/605090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605090</ArticleId><ArticleId IdType="pubmed">19622041</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu PY, Tyan YC, Chen YS, Chen HL, Lu PL, Chen YH, Chen BC, Huang TS, Wang CF, Su HJ, et al. Transmission and demographic dynamics of Coxsackievirus B1. PLoS ONE. 2015;10(6):e0129272. doi: 10.1371/journal.pone.0129272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0129272</ArticleId><ArticleId IdType="pmc">PMC4460132</ArticleId><ArticleId IdType="pubmed">26053872</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Du J, Xue Y, Su H, Yang F, Jin Q. Epidemics and frequent recombination within species in outbreaks of human enterovirus B-associated hand, foot and mouth disease in Shandong China in 2010 and 2011. PLoS ONE. 2013;8(6):e67157. doi: 10.1371/journal.pone.0067157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067157</ArticleId><ArticleId IdType="pmc">PMC3686723</ArticleId><ArticleId IdType="pubmed">23840610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H, Fan H, Lu PX, Zhang XF, Ai J, Shi C, Huo X, Bao CJ, Shan J, Jin Y. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden. BMC Infect Dis. 2019;19(1):79. doi: 10.1186/s12879-018-3659-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3659-7</ArticleId><ArticleId IdType="pmc">PMC6341624</ArticleId><ArticleId IdType="pubmed">30669973</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H, Wang J, Wang C, Yang M, Liu L, Yang G, Ma X. Etiology of multiple non-EV71 and non-CVA16 enteroviruses associated with hand, foot and mouth disease in Jinan, China, 2009&#x2013;June 2013. PLoS ONE. 2015;10(11):e0142733. doi: 10.1371/journal.pone.0142733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142733</ArticleId><ArticleId IdType="pmc">PMC4642993</ArticleId><ArticleId IdType="pubmed">26562154</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>